CoChat

Long-term impact of sarcopenia on functional decline and mortality in community-dwelling older adults: a systematic review and meta-analysis

Zhao, Yuan, Jiang, Yueying, Guo, Yunyu, Pan, Wanya, Tian, Wenhao, Tang, Leiwen, Feng, Xiuqin · 2026 · Frontiers in Nutrition
Cited by 19

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Sarcopenia is an age-related syndrome characterized by progressive loss of muscle mass and function. While it is considered a key predictor of adverse health outcomes, comprehensive evidence regarding its long-term impact on functional decline and mortality in community-dwelling older adults remains limited. Objective: To evaluate the longitudinal association between baseline sarcopenia and risks of functional decline and all-cause mortality among community-dwelling older adults, with subgroup analyses based on methods of sarcopenia assessment and domains of functional decline. Methods: We conducted a systematic review and meta-analysis following PRISMA 2020 and MOOSE guidelines. Seven databases were searched from inception to September 30 th , 2025. We included cohort studies of older adults aged 60 years and above, with sarcopenia defined by recognized criteria, and reporting effect estimates for functional decline or mortality with follow-up for 1 year or longer. A meta-analysis based on heterogeneity was conducted using either common or random-effects models. Results: A total of 39 studies involving 76151 participants were included. Sarcopenia was significantly associated with an increased risk of all-cause mortality (29 publications, OR = 1.79, 95%CI: 1.55~2.06) and functional decline (16 publications, OR = 1.90, 95%CI: 1.55~2.32). Subgroup analyses revealed consistent associations across different muscle mass assessment methods (DXA, BIA, and CT). Notably, sarcopenia was associated with both physical (OR = 1.91, 95%CI: 1.52~2.40) and cognitive/psychological functional decline (OR = 2.03, 95%CI: 1.35~3.05). Heterogeneity was moderate to high but did not substantially alter the results in sensitivity analyses. Conclusion: This meta-analysis confirms that sarcopenia significantly predicts long-term functional decline and mortality in community-dwelling older adults, with robust associations across multiple muscle mass measurement methods and functional domains. These findings highlight the importance of standardized sarcopenia screening and early intervention to mitigate long-term functional impairment and mortality risk in aging populations. Clinical trial registration: PROSPERO (ID CRD42024595362).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnut.2025.1652386

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 59

  1. Cruz-Jentoft, 2019, Sarcopenia: revised European consensus on definition and diagnosis, Age Ageing, 48, 601, 10.1093/ageing/afz046 · DOI · Paper page
  2. Liu, 2021, Expert consensus on diagnosis and treatment of sarcopenia in Chinese elderly (2021), Chin J Geriatr, 40, 943
  3. Liu, 2024, Frontiers in sarcopenia: advancements in diagnostics, molecular mechanisms, and therapeutic strategies, Mol Asp Med, 97, 101270, 10.1016/j.mam.2024.101270 · DOI
  4. Supriya, 2021, A multifactorial approach for sarcopenia assessment: a literature review, Biology, 10, 10.3390/biology10121354 · DOI
  5. Yu, 2021, Chinese expert consensus on core messages for prevention of hypomyelitis in older adults (2021), Chin J Geriatr, 40, 953
  6. Beaudart, 2017, Health outcomes of sarcopenia: a systematic review and Meta-analysis, PLoS One, 12, e0169548, 10.1371/journal.pone.0169548 · DOI · Paper page
  7. Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z · DOI · Paper page
  8. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  9. DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  10. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  11. Sterne, 2011, Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials, BMJ, 343, d4002, 10.1136/bmj.d4002 · DOI · Paper page
  12. De Santana, 2019, Association of appendicular lean mass, and subcutaneous and visceral adipose tissue with mortality in older Brazilians: the São Paulo Ageing & Health Study, J Bone Miner Res, 34, 1264, 10.1002/jbmr.3710 · DOI
  13. Yamaguchi, 2023, Association of sarcopenia and systolic blood pressure with mortality: a 5-year longitudinal study, Arch Gerontol Geriatr, 110, 104988, 10.1016/j.archger.2023.104988 · DOI
  14. Tanimoto, 2013, Association of sarcopenia with functional decline in community-dwelling elderly subjects in J apan, Geriatr Gerontol Int, 13, 958, 10.1111/ggi.12037 · DOI · Paper page
  15. Lenchik, 2021, Automated muscle measurement on chest CT predicts all-cause mortality in older adults from the National Lung Screening Trial, J Gerontol A Biol Sci Med Sci, 76, 277, 10.1093/gerona/glaa141 · DOI
  16. Björkman, 2019, Bioimpedance analysis and physical functioning as mortality indicators among older sarcopenic people, Exp Gerontol, 122, 42, 10.1016/j.exger.2019.04.012 · DOI
  17. Yao, 2024, Clinical, functional, and opportunistic CT metrics of sarcopenia at the point of imaging care: analysis of all-cause mortality, Skeletal Radiol, 53, 515, 10.1007/s00256-023-04438-w · DOI
  18. Oh, 2023, Combinations of sarcopenia diagnostic criteria by Asian working Group of Sarcopenia (AWGS) 2019 guideline and incident adverse health outcomes in community-dwelling older adults, J Am Med Dir Assoc, 24, 1185, 10.1016/j.jamda.2023.04.005 · DOI
  19. Jang, 2018, Comparisons of predictive values of sarcopenia with different muscle mass indices in Korean rural older adults: a longitudinal analysis of the aging study of PyeongChang rural area, Clin Interv Aging, 13, 91, 10.2147/CIA.S155619 · DOI · Paper page
  20. Chiba, 2021, Difference in sarcopenia characteristics associated with physical activity and disability incidences in older adults, J Cachexia Sarcopenia Muscle, 12, 1983, 10.1002/jcsm.12801 · DOI
  21. Ishii, 2020, Effects of comorbid physical frailty and low muscle mass on incident disability in community-dwelling older adults: a 24-month follow-up longitudinal study, Maturitas, 139, 57, 10.1016/j.maturitas.2020.04.018 · DOI
  22. Tang, 2018, FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-Lan longitudinal aging study, J Gerontol A Biol Sci Med Sci, 73, 828, 10.1093/gerona/glx148 · DOI
  23. Thompson, 2021, Frailty and sarcopenia in combination are more predictive of mortality than either condition alone, Maturitas, 144, 102, 10.1016/j.maturitas.2020.11.009 · DOI
  24. Peng, 2023, Grip strength and sarcopenia predict 2-year cognitive impairment in community-dwelling older adults, J Am Med Dir Assoc, 24, 292, 10.1016/j.jamda.2022.10.015 · DOI
  25. Costanzo, 2020, Impact of low muscle mass and low muscle strength according to EWGSOP2 and EWGSOP1 in community-dwelling older people, J Gerontol A Biol Sci Med Sci, 75, 1324, 10.1093/gerona/glaa063 · DOI
  26. Shim, 2025, Impact of sarcopenia on falls, mobility limitation, and mortality using the diagnostic criteria proposed in the Korean working group on sarcopenia guideline, Ann Geriatr Med Res, 29, 38, 10.4235/agmr.24.0131 · DOI
  27. Li, 2022, Independent and joint associations of skeletal muscle mass and physical performance with all-cause mortality among older adults: a 12-year prospective cohort study, BMC Geriatr, 22, 597, 10.1186/s12877-022-03292-0 · DOI
  28. Liang, 2023, Long-term mortality risk in older adults with sarcopenia: an 11-year prospective cohort study comparing AWGS 2014 and AWGS 2019 guidelines for enhanced clinical utility and accurate risk prediction, J Nutr Health Aging, 27, 507, 10.1007/s12603-023-1940-y · DOI
  29. Amigues, 2013, Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study, J Am Med Dir Assoc, 14, 352, 10.1016/j.jamda.2012.12.002 · DOI
  30. Balogun, 2017, Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults, J Nutr Health Aging, 21, 843, 10.1007/s12603-016-0843-6 · DOI · Paper page
  31. Ramoo, 2024, Sarcopenia and all-cause mortality risk in community-dwelling rural malaysian older adults, Asia Pac J Public Health, 36, 225, 10.1177/10105395241237811 · DOI
  32. Uemura, 2019, Sarcopenia and low serum albumin level synergistically increase the risk of incident disability in older adults, J Am Med Dir Assoc, 20, 90, 10.1016/j.jamda.2018.06.011 · DOI
  33. Brown, 2016, Sarcopenia and mortality among a population-based sample of community-dwelling older adults, J Cachexia Sarcopenia Muscle, 7, 290, 10.1002/jcsm.12073 · DOI · Paper page
  34. Pereira, 2022, Sarcopenia and mortality risk in community-dwelling brazilian older adults, Sci Rep, 12, 17531, 10.1038/s41598-022-22153-9 · DOI
  35. Pérez-Zepeda, 2017, Sarcopenia and post-hospital outcomes in older adults: a longitudinal study, Arch Gerontol Geriatr, 69, 105, 10.1016/j.archger.2016.10.013 · DOI
  36. Bachettini, 2020, Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the european working group on sarcopenia in older people, Eur J Clin Nutr, 74, 573, 10.1038/s41430-019-0508-8 · DOI
  37. Yuki, 2017, Sarcopenia based on the Asian working Group for Sarcopenia criteria and all-cause mortality risk in older Japanese adults, Geriatr Gerontol Int, 17, 1642, 10.1111/ggi.12946 · DOI
  38. Sim, 2019, Sarcopenia definitions and their associations with mortality in older Australian women, J Am Med Dir Assoc, 20, 76, 10.1016/j.jamda.2018.10.016 · DOI
  39. Takahashi, 2021, Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus, Front Endocrinol, 12, 783363, 10.3389/fendo.2021.783363 · DOI
  40. Hirani, 2015, Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the Concord health and ageing in men project, J Am Med Dir Assoc, 16, 607, 10.1016/j.jamda.2015.02.006 · DOI · Paper page
  41. Frisoli Junior, 2025, Sarcopenia predicts mortality in older adults with cardiovascular disease: concordant findings from SDOC and EWGSOP II criteria despite limited role of low lean mass, Maturitas, 199, 108618, 10.1016/j.maturitas.2025.108618 · DOI
  42. Sobestiansky, 2019, Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study, BMC Geriatr, 19, 318, 10.1186/s12877-019-1338-1 · DOI
  43. Wang, 2019, Skeletal muscle mass as a mortality predictor among nonagenarians and centenarians: a prospective cohort study, Sci Rep, 9, 2420, 10.1038/s41598-019-38893-0 · DOI · Paper page
  44. Ulugerger Avci, 2023, The impact of sarcopenia and obesity on mortality of older adults: five years results, Ir J Med Sci (1971 -), 192, 2209, 10.1007/s11845-023-03392-9 · DOI
  45. Uemura, 2018, The impact of sarcopenia on incident homebound status among community-dwelling older adults: a prospective cohort study, Maturitas, 113, 26, 10.1016/j.maturitas.2018.03.007 · DOI
  46. Zhang, 2023, The longitudinal bidirectional association between sarcopenia and cognitive function in community-dwelling older adults: findings from the China health and retirement longitudinal study, J Glob Health, 13, 04182, 10.7189/jogh.13.04182 · DOI
  47. Locquet, 2019, Three-year adverse health consequences of sarcopenia in community-dwelling older adults according to 5 diagnosis definitions, J Am Med Dir Assoc, 20, 43, 10.1016/j.jamda.2018.06.004 · DOI
  48. Chen, 2019, Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia, J Am Med Dir Assoc, 20, 64, 10.1016/j.jamda.2018.07.017 · DOI
  49. Nakano, 2024, Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults, Bone, 179, 116975, 10.1016/j.bone.2023.116975 · DOI
  50. Zuo, 2023, Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 14, 1183, 10.1002/jcsm.13221 · DOI · Paper page
  51. Shu, 2022, Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 145, 10.1002/jcsm.12890 · DOI · Paper page
  52. Fang, 2023, The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 14, 3, 10.1002/jcsm.13126 · DOI
  53. Peng, 2020, Sarcopenia and cognitive impairment: a systematic review and meta-analysis, Clin Nutr Edinb Scotl, 39, 2695, 10.1016/j.clnu.2019.12.014 · DOI · Paper page
  54. Beaudart, 2023, Sarcopenia and health-related quality of life: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 14, 1228, 10.1002/jcsm.13243 · DOI · Paper page
  55. Li, 2022, Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 128, 10.1002/jcsm.12908 · DOI · Paper page
  56. Cheng, 2021, The optimal strategy of vitamin D for sarcopenia: a network Meta-analysis of randomized controlled trials, Nutrients, 13, 10.3390/nu13103589 · DOI · Paper page
  57. De Felice, 2025, Progress and challenges in integrating nutritional care into oncology practice: results from a National Survey on behalf of the NutriOnc research group, Nutrients, 17, 188, 10.3390/nu17010188 · DOI
  58. Hämäläinen, 2025, Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial, Aging Clin Exp Res, 37, 36, 10.1007/s40520-025-02935-7 · DOI
  59. Zhu, 2025, Exploring the mediating roles of depression and cognitive function in the association between sarcopenia and frailty: a cox survival analysis approach, J Adv Res, 76, 605, 10.1016/j.jare.2024.12.021 · DOI

Metadata

Authors
Zhao, Y., Jiang, Y., Guo, Y., Pan, W., Tian, W., Tang, L., & Feng, X.
Venue
Frontiers in Nutrition
Published
2026-01-08
Volume
12
ISSN
2296-861X
Cited by
19
References
9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term impact of sarcopenia on functional decline and mortality in community-dwelling older adults: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.3389/fnut.2025.1652386
The paper
Zhao, Y., Jiang, Y., Guo, Y., Pan, W., Tian, W., Tang, L., & Feng, X. (2026). Long-term impact of sarcopenia on functional decline and mortality in community-dwelling older adults: a systematic review and meta-analysis. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2025.1652386

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.